322 related articles for article (PubMed ID: 32776321)
21. Precision Treatments in Epilepsy.
Demarest S; Brooks-Kayal A
Neurotherapeutics; 2021 Jul; 18(3):1429-1431. PubMed ID: 34704188
[No Abstract] [Full Text] [Related]
22. A Model Program for Translational Medicine in Epilepsy Genetics.
Smith LA; Ullmann JF; Olson HE; Achkar CM; Truglio G; Kelly M; Rosen-Sheidley B; Poduri A
J Child Neurol; 2017 Mar; 32(4):429-436. PubMed ID: 28056630
[TBL] [Abstract][Full Text] [Related]
23. Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.
Bauer S; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Rosenow F
Epilepsy Behav; 2017 Nov; 76():7-12. PubMed ID: 28917498
[TBL] [Abstract][Full Text] [Related]
24. New paradigms for the treatment of pediatric monogenic epilepsies: Progressing toward precision medicine.
Specchio N; Pietrafusa N; Perucca E; Cross JH
Epilepsy Behav; 2022 Jun; 131(Pt B):107961. PubMed ID: 33867301
[TBL] [Abstract][Full Text] [Related]
25. Precision therapy in the genetic epilepsies of childhood.
Byrne S; Enright N; Delanty N
Dev Med Child Neurol; 2021 Nov; 63(11):1276-1282. PubMed ID: 34089185
[TBL] [Abstract][Full Text] [Related]
26. A roadmap for precision medicine in the epilepsies.
EpiPM Consortium
Lancet Neurol; 2015 Dec; 14(12):1219-28. PubMed ID: 26416172
[TBL] [Abstract][Full Text] [Related]
27. Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology.
Carvill GL; Matheny T; Hesselberth J; Demarest S
Neurotherapeutics; 2021 Jul; 18(3):1500-1514. PubMed ID: 34648141
[TBL] [Abstract][Full Text] [Related]
28. Genetics and genomics: the scientific drivers of personalized medicine.
Kurnat-Thoma EL
Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision Medicine.
Rakicevic L; Nestorovic A
Clin Pharmacol Ther; 2019 Mar; 105(3):547-549. PubMed ID: 29920652
[TBL] [Abstract][Full Text] [Related]
30. Precision Medicine, Cardiovascular Disease and Hunting Elephants.
Joyner MJ
Prog Cardiovasc Dis; 2016; 58(6):651-60. PubMed ID: 26902518
[TBL] [Abstract][Full Text] [Related]
31. Personalized translational epilepsy research - Novel approaches and future perspectives: Part I: Clinical and network analysis approaches.
Rosenow F; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Bauer S
Epilepsy Behav; 2017 Nov; 76():13-18. PubMed ID: 28917501
[TBL] [Abstract][Full Text] [Related]
32. Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies.
Garcia-Rosa S; de Freitas Brenha B; da Rocha VF; Goulart E; Silva Araujo BH
Curr Neuropharmacol; 2021; 19(6):813-831. PubMed ID: 32933463
[TBL] [Abstract][Full Text] [Related]
33. Personalizing health care: feasibility and future implications.
Godman B; Finlayson AE; Cheema PK; Zebedin-Brandl E; Gutiérrez-Ibarluzea I; Jones J; Malmström RE; Asola E; Baumgärtel C; Bennie M; Bishop I; Bucsics A; Campbell S; Diogene E; Ferrario A; Fürst J; Garuoliene K; Gomes M; Harris K; Haycox A; Herholz H; Hviding K; Jan S; Kalaba M; Kvalheim C; Laius O; Lööv SA; Malinowska K; Martin A; McCullagh L; Nilsson F; Paterson K; Schwabe U; Selke G; Sermet C; Simoens S; Tomek D; Vlahovic-Palcevski V; Voncina L; Wladysiuk M; van Woerkom M; Wong-Rieger D; Zara C; Ali R; Gustafsson LL
BMC Med; 2013 Aug; 11():179. PubMed ID: 23941275
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics in the clinic.
Relling MV; Evans WE
Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
[TBL] [Abstract][Full Text] [Related]
35. Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies.
Dhindsa RS; Goldstein DB
Curr Neurol Neurosci Rep; 2015 Oct; 15(10):70. PubMed ID: 26319171
[TBL] [Abstract][Full Text] [Related]
36. Precision Medicine and the Changing Landscape of Research Ethics.
Hammer MJ
Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
[TBL] [Abstract][Full Text] [Related]
37. Individualizing pharmacogenomic test results in the context of the microbiome.
Haga SB
Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
[TBL] [Abstract][Full Text] [Related]
38. Precision diagnosis and precision treatment for the genetic epilepsies.
Majumder SN; Hamandi K
J Neurol; 2023 Jul; 270(7):3667-3669. PubMed ID: 37246996
[No Abstract] [Full Text] [Related]
39. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
[TBL] [Abstract][Full Text] [Related]
40. Treatment of epilepsy - towards precision.
Leach JP
F1000Res; 2018; 7():. PubMed ID: 30613377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
